The Ca 2+ /calmodulin-dependent protein kinase II (CaMK II) is a multifunctional enzyme which is widely expressed from yeast to mammals and occurs in four different isoforms termed a, b, g and d which are derived from different genes [1,2]. The highest concentrations are in the CNS where the aisoform and b-isoform are involved in neurotransmitter release [1,2] whereas the g-isoform and disoform occur in most peripheral cells [3,4] and participate in control of cell cycle, metabolism, gene expression and membrane excitability. Insulin secretion in response to glucose and other nutrient stimuli is dependent on Ca 2+ and CaMK II seems to play an important part in this process [5±7]. Impairment of insulin secretion in response to glucose is an early event in the development of adult Type II (non-insulin-dependent) diabetes mellitus making it Diabetologia (2000) Abstract Aims/hypothesis. The Ca 2+ /calmodulin-dependent protein kinase II (CaMK II) is highly expressed in pancreatic islets and associated with insulin secretion vesicles. The suppression of CaMK II disturbs insulin secretion and insulin gene expression. There are four isoforms of CaMK II, a to d, that are expressed from different genes in mammals. Our aim was to identify the isoforms of CaMK II expressed in human beta cells by molecular cloning from a human insulinoma cDNA library and to assess its distribution in humans. Methods. The previously unknown complete coding sequences of human CaMK IIb and the kinase domain of CaMK IId were cloned from a human insulinoma cDNA library. Quantitative determination of CaMK II isoform mRNA was carried out in several tissues and beta cells purified by fluorescence activated cell sorting and compared to the housekeeping enzyme pyruvate dehydrogenase. Results. We found CaMK IIb occurred in three splice variants and was highly expressed in endocrine tissues such as adrenals, pituitary and beta cells. Liver showed moderate expression but adipose tissue or lymphocytes had very low levels of CaMK IIbmRNA. In human beta cells CaMK IIb and d were expressed equally with pyruvate dehydrogenase whereas tenfold lower expression of CaMK IIg and no expression of CaMK IIa were found. Conclusion/interpretation. Although CaMK IId is ubiquitously expressed, CaMK IIb shows preferential expression in neuroendocrine tissues. In comparison with the expression of a key regulatory enzyme in glucose oxidation, pyruvate dehydrogenase, two of the four CaM kinases investigated are expressed at equally high levels, which supports an important role in beta-cell physiology. These results provide the basis for exploring the pathophysiological relevance of CaMK IIb in human diabetes. [Diabetologia (2000) 43: 465±473]